2010—2012年山西省人民医院口服抗高血压药应用分析  

Utilization Analysis of Oral Antihypertensive Drugs in Shanxi Provincial People's Hospital During 2010-2012

作　　者：张慧[1] 彭芳辰[1] 

机构地区：[1]山西省人民医院临床药学科,太原030012

出　　处：《中国医院用药评价与分析》2014年第3期195-198,共4页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解我院口服抗高血压药的应用情况及趋势,为临床管理和合理用药提供参考。方法:采用回顾性方法,对2010—2012年我院口服抗高血压药的使用品种、销售金额、用药频度(DDDs)和限定日费用(DDC)进行统计和分析。结果:3年来,我院口服抗高血压药的销售金额和DDDs均呈上升趋势;钙通道阻滞剂(CCB)、血管紧张素Ⅱ受体阻断剂(ARB)、β受体阻断剂销售金额排序均居前3位,所占份额总和超过80%,由此可见这3类药为我院治疗高血压的主要口服药物;左氨氯地平片(施慧达)与氯沙坦钾片(科素亚)的销售金额排序和DDDs排序均居第1位和第2位,二者的比值(位次比)均为1,说明左氨氯地平片与氯沙坦钾片的使用金额与用药频度的同步性好。结论:我院口服抗高血压药应用基本合理,符合目前的抗高血压用药原则。OBJECTIVE ：To investigate the status quo and the developmental tendency of the oral antihypertensive drugs used in our hospital so as to provide reference for clinical management and rational use of antihypertensive drugs. METHODS： The varieties, consumption sum, DDDs and DDC（defined daily cost） of oral antihypertensive drugs used in our hospital during 2010-2012 were statistically analyzed using the retrospective method. RESULTS： Both the consumption sum and the DDDs of oral antihypertensive drugs in our hospital showed an upward trend over the 3 years.Calcium channel blockers （CCB）, Angiotensin II receptor blockers（ARB） and ^-blockers ranked among the top three in terms of consumption sum, and they represented more than 80% of the total sales, indicating these three types of drugs were the main oral drugs for treatment of hypertension in our hospital. The consumption sum and DDDs of levamlodipine besylate tablets and losartan potassium tablets （Cozaar） dominated the first and second place, respectively, with order ratio of 1 for both drugs, indicating good synchronization between consumption sum and DDDs of the two drugs. CONCLUSION ： The utilization of oral antihypertensive drugs in our hospital was rational on the whole and in line with the current oral antihypertensive medication principle.

关 键 词：口服抗高血压药销售金额用药频度限定日费用 

分 类 号：R972.4[医药卫生—药品]